MINDCURE Announces Financial Results for the First Quarter of Fiscal 2022

Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility...

PT268 – Hamilton Morris – PCP, 5-MeO-DMT, and The Synthesis of...

MindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program

HAVN Life Announces Departure of Rick Brar as Director

Delix Therapeutics Announces Appointment of Dr. John Krystal to Scientific &...

European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the...

MindMed CMO to Chair Digital Biomarkers Summit

Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial...

Psychedelic Bulletin: Small Pharma Secures Fast-Track Designation in UK; Boris Johnson...

Load more